Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 1/20 | 0.41 |
| ▸ | CDK9 | P50750 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 7/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 7/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 7/20 | 0.40 |
| ▸ | ABL1 | P00519 | 6/20 | 0.37 |
| ▸ | BTK | Q06187 | 6/20 | 0.37 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.36 |
| ▸ | BCR | P11274 | 2/20 | 0.35 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.34 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.34 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.34 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.34 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27553389 | 0.78 | MAPK1 (0.47) | CDK2CDK9KCNA5 | |
| SCHEMBL3306411 | 0.73 | CDK2 (0.41) | CDK2CDK9GABRG2GABRB3GABRA5 | |
| SCHEMBL3306416 | 0.73 | CDK2 (0.64) | CDK2CDK9 | |
| SCHEMBL27573680 | 0.68 | KCNA5 (0.39) | KCNA5 | |
| SCHEMBL27573678 | 0.65 | CDK2 (0.58) | CDK2CDK9KCNA5 | |
| SCHEMBL27780397 | 0.63 | NPSR1 (0.47) | CDK2CDK9MAPK14MAPK13MAPK12 | |
| SCHEMBL14415502 | 0.61 | CHRNB2 (0.41) | KCNA5 | |
| SCHEMBL3409401 | 0.61 | KCNA5 (0.49) | KCNA5 | |
| Hydrochloric Acid SCHEMBL28909526 | 0.60 | DRD2 (0.39) | — | |
| Hydrochloric Acid SCHEMBL29473038 | 0.60 | DRD2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101679434-B | 2, 6, 9-substituted purine derivatives having anti proliferative properties | CYCLACEL LTD | 2013-09-25 | — | — | CN | disclosed |
| CN-101679434-A | Has 2,6 of anti proliferative properties, the purine derivative that 9-replaces | CYCLACEL LTD | 2010-03-24 | — | — | CN | disclosed |